Key Clinical Biomarkers of Liver Diseases You Should Know
Chronic liver diseases (CLD) and cirrhosis are major global health challenges, accounting for over 2 million deaths annually. Additionally, 810,000 liver cancer-related deaths emphasize the need for timely diagnosis and management. Patients with cirrhosis, regardless of its cause, are at high risk of developing hepatocellular carcinoma (HCC), further compounding the healthcare burden.
Common Causes and Emerging Trends
The leading causes of CLD and cirrhosis include:
While HBV cases are declining due to vaccination programs and anti-viral treatments, HCV infections, NAFLD, and ALD are on the rise, driven by obesity, metabolic syndrome, and increased alcohol consumption.
Overview of What’s Inside -?
Explore the critical role of clinical biomarkers in addressing liver diseases and discover how Mindray is making a difference.
Pursuing Btech at Deenbandhu Chhotu Ram University o f Science & Technology in Biomedical engineering
4 周Very informative
Director @ UGS Training Co.| We help SMEs skyrocket their Sales Revenue through our sales training programs | Empowered 7000+ salespeople from 30+ industries | Track record of 20% - 60% sales revenue growth.
1 个月Totally agree! Mindray India Early detection is crucial. Incorporating AI in imaging could advance diagnostics. ?? Also, personalized medicine for liver disease is an exciting prospect. ??